Episode Details
Back to EpisodesClinical update with Dr. Daniel Griffin
Description
In his weekly clinical update, Dr. Griffin begins with discussing if the antibiotic neomycin is really a pan-antiviral countermeasure, then reviews the recent statistics on SARS-CoV-2 infection before deep diving into if shedding and the rapid antigen test results correlate, the guidelines for spring administration of COVID vaccines boosters, whether COVID booster associates with the long COVID prevalence, discusses the emergency use application of a pre-exposure prophylactic, revised guidelines for how to treat respiratory viral infection guidelines by the CDC, the caveats for improper use of antibiotics to treat SARS-CoV-2 (a viral infection), continues to dispel the myth of viral rebound, when to use steroids and the benefits of convalescent plasma, what do when healthcare workers succumb to SARS-CoV-2 infection, if administration of an anti-immunoglobulin E monoclonal antibody can be used for COVID-19 treatment, if inhibiting T-cell activation will reduce secretion and production of inflammatory cytokines including IL-6, if changes in the gut microbiome associate with post -acute COVID-19 syndrome, and the pulmonary and neurologic determinants of long COVID-19 such as the presence of neurofilament light chain in plasma. For more information about this body of work, listen to TWiV 1088.
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Intranasal antibiotic evokes antiviral response (PNAS)
- COVID-19 national trend (CDC)
- COVID-19 deaths (CDC)
- SARS-CoV-2 shedding vs rapid antigen test performance (MMWR)
- Spring vaccineadvice (CIDRAP)
- Older adult spring booster available (CDC)
- Advisory committee for immunization practices slides (CDC)
- Advisory committee for immunization practices spring 2024 COVID-19 boosters (CDC)
- COVID-19 booster take: cross-sectional study (Vaccine)
- EUA for pemgarda (FDA)
- CDC Quarantine guidelines (CDC)
- NIH COVID-19 treatment guidelines (NIH)
- Infectious Disease Society guidelines for treatment and management (IDSociety)
- Overuse of
Listen Now
Love PodBriefly?
If you like Podbriefly.com, please consider donating to support the ongoing development.
Support Us